![Frontiers | Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future Frontiers | Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future](https://www.frontiersin.org/files/Articles/718686/fimmu-12-718686-HTML/image_m/fimmu-12-718686-t001.jpg)
Frontiers | Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future
![PDF] Pharmacological Properties of Monoclonal Antibodies Directed Against Interleukins | Semantic Scholar PDF] Pharmacological Properties of Monoclonal Antibodies Directed Against Interleukins | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a3fe0546e18877aee2ca07b4dd09098e3a2efb48/4-Table1-1.png)
PDF] Pharmacological Properties of Monoclonal Antibodies Directed Against Interleukins | Semantic Scholar
![Table 1 from Expression of interleukin-10 family cytokines in rheumatoid arthritis | Semantic Scholar Table 1 from Expression of interleukin-10 family cytokines in rheumatoid arthritis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c9c98a5969ce397b4864407815bb35771888e63a/14-Table1-1.png)
Table 1 from Expression of interleukin-10 family cytokines in rheumatoid arthritis | Semantic Scholar
![Table 1 from Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist ( IL-1 Ra ) precede the onset of type 2 diabetes ( Whitehall II Study ) | Semantic Scholar Table 1 from Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist ( IL-1 Ra ) precede the onset of type 2 diabetes ( Whitehall II Study ) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/101d47da44b4dcf8420506f76e093002106d8413/7-Table1-1.png)
Table 1 from Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist ( IL-1 Ra ) precede the onset of type 2 diabetes ( Whitehall II Study ) | Semantic Scholar
![Frontiers | Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges Frontiers | Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges](https://www.frontiersin.org/files/MyHome%20Article%20Library/515658/515658_Thumb_400.jpg)
Frontiers | Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges
![Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/29b7b229-d211-4358-bd04-a3f6a57b5f14/gr1.jpg)